Attar, Sabah
Price, Angie
Hovinga, Collin
Stewart, Breanne
Lacaze-Masmonteil, Thierry
Bonifazi, Fedele
Turner, Mark A.
Fernandes, Ricardo M.
Funding for this research was provided by:
Innovative Medicines Initiative (777389)
Canadian Institute for Health Research
Food and Drug Administration
Article History
Received: 20 December 2023
Accepted: 1 May 2024
First Online: 20 June 2024
Declarations
:
: The publication reflects the authors’ view and neither IHI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein. Thierry Lacaze-Masmonteil is the Scientific Director of the organization MICYRN, and Breanne Stewart is Project Manager for Special Initiatives.